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Abstract
Human mesenchymal stem cells (hMSCs) are motile cells that migrate from their native
niche to wounded sites where they regulate inflammation during healing. New materials
are being developed as hMSC delivery platforms to enhance wound healing. To act as
an effective wound healing material, the hydrogel must degrade at the same rate as tis-
sue regeneration while maintaining high cell viability. This work determines the kinetics
and mechanism of cell-mediated degradation in hMSC-laden poly(ethylene glycol) (PEG)
hydrogels. We use a well-established hydrogel scaffold that is composed of a backbone
of four-arm star PEG functionalized with norbornene that is cross-linked with a matrix
metalloproteinase (MMP) degradable peptide. This peptide sequence is cleaved by cell-
secreted MMPs, which allow hMSCs to actively degrade the hydrogel during motility.
Three mechanisms of degradation are characterized: hydrolytic, non-cellular enzymatic
and cell-mediated degradation. We use bulk rheology to characterize hydrogel material
properties and quantify degradation throughout the entire reaction. Hydrolysis and non-
cellular enzymatic degradation are first characterized in hydrogels without hMSCs, and
follow first-order and Michaelis-Menten kinetics, respectively. High cell viability is mea-
sured in hMSC-laden hydrogels, even after shearing on the rheometer. After confirming
hMSC viability, bulk rheology characterizes cell-mediated degradation. When comparing
cell-mediated degradation to non-cellular degradation mechanisms, cell-mediated degrada-
tion is dominated by enzymatic degradation. This indicates hydrogels with hMSCs are
degraded primarily due to cell-secreted MMPs and very little network structure is lost
due to hydrolysis. Modeling cell-mediated degradation provides an estimate of the initial
concentration of MMPs secreted by hMSCs. By changing the concentration of hMSCs, we
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determine the initial MMP concentration increases with increasing hMSC concentration.
This work characterizes the rate and mechanism of scaffold degradation, giving new insight
into the design of these materials as implantable scaffolds.
2
Chapter 1
Introduction
Hydrogel scaffolds have become an important class of biomaterials with applications in
tissue regeneration, wound healing and 3D cell culture [1–26]. These hydrogels can be
composed of biologic or synthetic materials and are being designed as implantable scaf-
folds to enhance wound healing and tissue regeneration [3–8,27–31]. Within wound healing
and regenerative medicine, these hydrogels are used to deliver drugs, proteins or cells in
vivo to specified locations within the body [3–7, 25, 27, 28, 32, 33]. The encapsulation of
human mesenchymal stem cells (hMSCs) is of particular interest because they are motile
cells that naturally migrate from their native niche to wound sites to regulate inflamma-
tion, the immune response and healing [25,28,32,34–36]. In order for hMSCs to be motile,
they secrete enzymes called matrix metalloproteinases (MMPs), which enable hMSCs to
degrade the extracellular matrix and move through their microenvironment [1,6,32,37,38].
Their ability to differentiate into various cell types, including bone, cartilage, muscle and
adipose tissue, also plays an important role in tissue regeneration [34, 36]. If implantable
and degradable hydrogels can deliver additional hMSCs to a wound, the rate of wound
healing and tissue regeneration can be increased. To do this, hydrogels must enable high
cell viability after encapsulation, provide structure to the tissue of interest and degrade at
the same rate as tissue regeneration. Our work determines the kinetics and mechanism of
cell-mediated degradation for a well-defined poly(ethylene glycol) (PEG)-peptide hydro-
gel. This work provides critical information that can be optimized in the design of new
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implantable tissue engineering or wound healing scaffolds.
PEG-based hydrogels have been used extensively as synthetic scaffolds for 3D cell encap-
sulation to determine the feasibility of these materials as implantable scaffolds [1,3,4,11,16–
18,33]. PEG hydrogels are biocompatible and can be designed to mimic the stiffness of soft
tissues, providing an environment that promotes basic cellular processes [3,7,10]. Alterna-
tive materials include biologic hydrogels, which are scaffolds that incorporate components
such as alginate, gelatin and proteins, such as collagen. These materials are biodegradable
and biocompatible [3, 7, 13, 29]. However, there are advantages to using synthetic PEG
hydrogels over biologic hydrogels. First, biologic hydrogels are weaker mechanically and
more prone to contamination [7]. Synthetic hydrogels have more controllable mechanical
and chemical properties. They can also be tailored to cross-link with a wide range of
chemistries and reaction schemes to form hydrogels within a wound site [8,11]. Unlike bio-
logic hydrogels, synthetic PEG hydrogels can be designed to controllably present biological
or physical cues to encapsulated hMSCs. Biological scaffolds mimic the native extracel-
lular matrix, including presentation of native physical and chemical cues that cannot be
engineered [19]. Additionally, PEG hydrogels are hydrophilic, enabling them to absorb
relatively large amounts of water-based media to maintain high cell viability [17]. Their
high mass transport capabilities and minimal protein adsorption makes PEG hydrogels an
excellent material for cell encapsulation [4].
Due to the advantages of synthetic PEG hydrogels for cell encapsulation applications,
we use PEG as the backbone for our scaffolds. In our hydrogel scaffold, multi-arm PEG
is functionalized with norbornene anhydride to create end-terminated PEG-norbornene
molecules [10,24,33]. PEG is cross-linked with a MMP degradable cross-linker, KCGPQG
↓ IWGCK. This cross-linker is chosen because it is degraded by hMSC-secreted MMPs
during basic cellular processes. Additionally, this cross-linker is degraded at a faster rate
when compared to other MMP degradable peptide cross-linkers that better mimic colla-
gen, because this sequence contains tryptophan instead of alanine [14]. This cross-linker is
important for biomedical applications, since hydrogels that degrade more rapidly in vivo
can lead to improved healing [14]. This scaffold is cross-linked using a photopolymerized
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step-growth reaction of thiols in the MMP degradable cross-linker and -enes in the nor-
bornene. This reaction is used because it provides relatively high mechanical integrity,
occurs at neutral pH and allows for better spatial and temporal control of the hydrogel
formed when compared to other step-growth reactions [10,24,33].
After encapsulating hMSCs in our degradable PEG-norbornene (PEG-N) hydrogel,
cell-mediated degradation is quantitatively characterized. In our work, bulk rheology is
used to measure the change in the material properties of hMSC-laden hydrogels. These
measurements determine the rate and mechanism of cell-mediated degradation. Rheology
measures the deformation and flow of a material [39]. In our work, small amplitude oscilla-
tory shear is used to measure the scaffold material properties. Bulk rheology characterizes
the complex modulus of the material, G∗ (ω), using
G∗(ω) = G′(ω) + iG′′(ω) (1.1)
where ω is frequency, i is the unit imaginary number, G′ is the storage or elastic modulus
and G′′ is the viscous or loss modulus. Focusing primarily on G′, these measurements char-
acterize the material’s elastic response and can be used to calculate gel stiffness [40–44].
Elastic modulus and stiffness are important parameters in cell motility and hydrogel degra-
dation [20, 21, 29, 45, 46]. In addition to bulk rheology, microrheology can also be used
to characterize microenvironmental evolution around encapsulated cells [1, 20, 45, 47–52].
Microrheological measurements are in the low moduli and large dynamic frequency range,
making them a complimentary measurement technique to bulk rheology [1,20,47–50,52,53].
Specifically, multiple particle tracking microrheology (MPT), a passive microrheological
technique, has been used to measure temporal and spatial pericellular material properties
in cell-laden hydrogels. Using microrheology, previous work has determined important
information about cell-material interactions and how cells shape and degrade their hy-
drogel microenvironment. However, minimal work has used bulk rheology to determine
the material properties and degradation mechanisms during cell-laden hydrogel degrada-
tion [1, 2, 19, 51, 54–57]. Therefore, our work focuses on the rheological properties and
degradation mechanisms of PEG-N hMSC-laden hydrogels by measuring their evolving
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elastic modulus, G′, during scaffold degradation. These results can be combined with mi-
crorheological measurements to provide a more complete picture at the macroscopic and
microscopic length scales.
Using bulk rheology, degradation mechanisms for hydrogels with hMSCs are character-
ized. Cell-mediated scaffold degradation is necessary for the survival of cells in the scaffold
and can be manipulated by physical cues in the scaffold to enhance cell delivery during
wound healing and tissue regeneration. During motility, cells stretch, adhere and degrade
pathways through the scaffold. This cell-mediated degradation changes the material prop-
erties, scaffold structure and kinetics of degradation [2, 12, 19, 46, 58–61]. Our hydrogel
scaffold has two mechanisms of degradation: hydrolytic and enzymatic degradation. In
order to understand the cell-mediated degradation rate, we must first characterize scaffold
degradation by both mechanisms without cells [1, 14,15,22,29].
We use bulk rheology to characterize hydrogel degradation with and without hMSCs.
The goal is to determine the kinetics and mechanism of hMSC-mediated hydrogel degrada-
tion. Hydrolytic and enzymatic degradation of the PEG-N scaffold without encapsulated
hMSCs is characterized. Models are developed to describe both degradation mechanisms.
Hydrolysis is modeled using first-order kinetics. Michaelis-Menten kinetics are used to
model enzymatic degradation. Hydrolytic and enzymatic kinetic constants are determined.
Cell-mediated scaffold degradation is then characterized. High hMSC viability is measured
in these scaffolds prior to and after shear is applied during bulk rheological characteri-
zation. Hydrolytic and enzymatic models are fit to experimental data of cell-mediated
degradation for hMSC-laden hydrogels. This determines the contributions of hydrolytic
and cell-secreted enzymatic degradation in the overall hMSC-laden hydrogel degradation.
Our work finds that cell-mediated degradation is dominated by cell-secreted enzymatic
degradation and there is minimal hydrolytic degradation. By understanding how hMSCs
degrade the pericellular region, hydrogels can be designed to more accurately manipulate
cellular responses and the rate of scaffold degradation [9,12,19,25,29,58]. With knowledge
of the hydrogel macroscopic material properties, combined with an understanding of how
encapsulated hMSCs degrade hydrogels, these materials can be optimized for applications
6
including implantable wound healing and tissue regeneration scaffolds.
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Chapter 2
Materials and Methods
2.1 hMSC culture
hMSCs are purchased from the Lonza Group in passage 2. Frozen hMSCs are resuspended
in 4 mL of growth medium, which consists of 1 g/L D-glucose DMEM (Thermo Fisher
Scientific), 10% fetal bovine serum (FBS, Thermo Fisher Scientific), 50 µmol mL−1 peni-
cillin/streptomycin (Thermo Fisher Scientific), 0.5 µg mL−1 fungizone (Thermo Fisher
Scientific) and 1 ng mL−1 recombinant human fibroblast growth factor (FGF, Peprotech,
Inc.). This growth medium will be referred to as growth medium with FGF. hMSCs are
pelleted and resuspended in 200 to 400 µL of growth medium with FGF, and are then
added to a cell culture plate (150× 25 mm Style Treated Cell Culture Dish, Corning Inc.)
containing 40 − 60 mL of growth medium with FGF. This cell culture plate is incubated
at 37◦C and 5% CO2 (Galaxy 48R, New Brunswick Scientific Co., Inc.) [19, 25]. Growth
medium with FGF is replenished after 3 days, which washes away any non-adherent hM-
SCs. After achieving 70 − 80% confluency, cells are either frozen in 95% 1× Dulbecco’s
Phosphate Buffered Saline (PBS, VWR Life Science) and 5% dimethyl sulfoxide (DMSO,
Sigma-Aldrich Corporation) and returned to the −130◦C freezer, are passaged or remain
in incubation for encapsulation. For passaging, 8 mL of a 0.25% trypsin-EDTA solution
(Thermo Fischer Scientific) is added to the cell culture plate for 10 to 15 minutes to remove
hMSCs from the bottom of the plate. 4 mL of growth medium with FGF is added to the
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2.2. DEVICE FABRICATION
cell culture plate, and all liquid is centrifuged for 5 minutes at 2600 RPM, resulting in a
pellet of hMSCs. The liquid is decanted and hMSCs are resuspended in 200 to 400 µL of
PBS. hMSCs are then counted to determine the cell concentration from this passage. Cells
are resuspended to the desired cell concentration during hydrogel fabrication, as discussed
below. For all experiments, hMSCs are used in passage 2− 6, and after passage 6, hMSCs
are discarded.
2.2 Device fabrication
Hydrogels are made in custom sample chambers in a glass-bottomed petri dish (d = 35 mm,
no. 1.5 glass coverslip, MatTek Corporation). A polydimethylsiloxane (PDMS, Sylgard)
cylindrical chamber with a 10 mm outer diameter and 8 mm inner diameter is made using
biopsy punches (Integra Biosciences). The PDMS chamber is then loosely attached to the
bottom of the glass-bottomed petri dish using ultraviolet (UV) curing adhesive (Norland
Optical Adhesive 81, Norland Products Inc.) which is cured with UV light at 365 nm for
3 minutes. This adhesive allows for sufficient attachment to the petri dish but also allows
for removal of the PDMS chamber. The PDMS chamber is used to hold the polymer
precursor solution during the gelation process and is removed following gelation to enable
equal swelling (in growth medium) in the axial and radial directions.
2.3 Hydrogel fabrication
Our hydrogel scaffold is composed of a four-arm star PEG-norbornene backbone (Mn 20,000
g/mol, 3 mM, Sigma-Aldrich Corporation) cross-linked by a MMP degradable peptide,
KCGPQG↓IWGCK (Mn 1,305 g/mol, 3.9 mM, Bachem). This scaffolds is well-established
for 3D cell encapsulation [4, 14, 25]. Hydrogels are photopolymerized with a thiol:ene
stoichiometric ratio of 0.65 [1, 9, 10, 22, 33]. A 0.65 thiol:ene ratio is a low cross-linking
density, which results in a low modulus material. In previous studies, this scaffold and
cross-linking density has been shown to enable a high percentage of cells migrating within
the hydrogel [25]. As discussed previously, since PEG-N scaffolds provide no physical
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2.4. HYDROGEL DEGRADATION
or chemical cues in the environment, an adhesion ligand CRGDS (Mn 594 g/ mol, 1
mM, American Peptide Company), is included to facilitate cell adhesion to the hydrogel
[22]. Lithium phenyl-2,4,6-trimethylbenzoylphosphate, a photoinitiatior synthesized using
previously published protocols (LAP, 1.7 mM), is included to initiate the reaction [62].
For scaffolds without hMSCs, the polymer precursor solution is described above. For
hMSC-laden hydrogels, hMSCs are added to the polymer precursor solution prior to gela-
tion and are encapsulated at a final concentration of 2× 105 cells/mL. Note that this low
cell concentration is used to limit cell-cell interactions within the hydrogel, so that we mea-
sure only cell-material interactions. For all scaffolds, 100 µL of polymer precursor solution
is pipetted into the 8 mm sample chamber described above. The solution is exposed to UV
light (365 nm, Analytik Jena US) for 3 minutes to initiate gelation. A cross-linked network
forms through a radically mediated thiol:ene step-growth mechanism. Previous work has
shown that UV exposure leads to successful 3D cell encapsulation and does not damage or
kill the majority of hMSCs [10, 62]. After gelation, the PDMS chamber is removed from
the sample chamber to allow the gel to swell isotropically. The hydrogel is incubated in 3
mL of growth medium without FGF at 37◦C and 5% CO2.
2.4 Hydrogel degradation
Three types of hydrogel degradation are characterized: hydrolytic, non-cellular enzymatic
and cell-mediated degradation. In hydrolysis, the ester linkage in PEG molecules is hy-
drolyzed. This occurs when the scaffold is incubated in water-based growth medium, and
results in degradation of hydrogels over the course of approximately two weeks. For these
experiments, hydrogels are incubated in growth medium without FGF at 37◦C and 5%
CO2 throughout the entire degradation reaction. They are only removed immediately be-
fore characterization on the bulk rheometer. On the rheometer, hydrogels are incubated
in an immersion cup (TA Instruments) filled with 6 mL of growth medium without FGF
at 37◦C.
Non-cellular enzymatic degradation is initiated by incubating hydrogels without hMSCs
in a solution of collagenase, which is a solution of enzymes including MMPs. The enzymes
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2.5. BULK RHEOLOGY
cleave the MMP degradable cross-linker in the hydrogel, resulting in degradation. In our
experiments, we use a 0.3 mg/mL collagenase solution (Fisher BioReagents). This solution
degrades the hydrogel over several hours, on a much faster time scale than hydrolytic
degradation. For these experiments, hydrogels are incubated in an immersion cup filled
with 6 mL of collagenase at 37◦C on the rheometer. The elastic moduli is measured at
timed intervals over the entire degradation reaction.
Cell-mediated degradation is measured in hMSC-laden hydrogel scaffolds. For these
experiments, hMSCs are encapsulated in the hydrogel, which are incubated in growth
medium without FGF. Following encapsulation, hMSCs secrete MMPs that degrade the
MMP degradable cross-linker within the gel. This degradation allows hMSCs to shape their
environment in order to move through the hydrogel. For these experiments, hydrogels are
kept in the incubator until running the scaffold on the rheometer. On the rheometer,
hydrogels are incubated in an immersion cup filled with 6 mL of growth medium without
FGF at 37◦C. Rheological measurements characterize hydrogel degradation over the five
day degradation period.
2.5 Bulk rheology
Prior to bulk rheology measurements, petri dish sample chambers are removed from the
incubator, and growth medium without FGF is removed from the inside of the petri dish.
The hydrogel is removed from the sample chamber. The hydrogel is then cut using an 8
mm biopsy punch to ensure the hydrogel diameter matches the diameter of the geometry.
Rheological properties are measured with a bulk rheometer (Ares G2, TA Instruments)
using an 8 mm parallel plate, which is sandblasted to minimize slip. All hydrogels are
incubated during measurements. An immersion cup is fixed to the Peltier plate and filled
with 6 mL of solution. For hydrolysis and cell-mediated degradation, the hydrogels are
incubated in growth medium without FGF at 37◦C. This provides hMSC-laden hydrogels
with growth medium during bulk rheology experiments. Non-cellular enzymatic hydrogels
are incubated in 6 mL of collagenase during bulk rheological measurements. A frequency
sweep from 0.1 to 40 Hz at 1% strain is used to measure the moduli in each hydrogel
11
2.6. CELL VIABILITY
sample.
2.6 Cell viability
To assess hMSC viability, a Live/Dead Viability Assay Kit (Thermo Fisher Scientific) is
used to differentiate live and dead cells based on the integrity of the cell membranes [4]. The
green-fluorescent calcein-AM highlights intracellular esterase activity found in live cells,
while the red-fluorescent ethidium homodimer-1 enters the degraded plasma membrane
found in dead cells [63]. Viability tests are completed by removing all growth medium
from the sample chamber and pipetting 1 mL of the Live/Dead Viability Assay solution
directly onto the hydrogel. The solution is left on the hydrogel for 30 to 60 minutes. The
scaffold is then imaged on an inverted fluorescent microscope (Axio Observer Z1, Zeiss)
using a 10× objective to capture images of red and green staining. Quantitative analysis
is completed in ImageJ (NIH Image) by counting live and dead cells.
12
Chapter 3
Results and Discussion
This thesis has been submitted for publication: Michelle S. Mazzeo, Tiffanie Chai and
Kelly M. Schultz. Characterization of the kinetics and mechanism of degradation of human
mesenchymal stem cell-laden poly(ethylene glycol) hydrogels. Submitted, 2018.
The overall goal of this work is to characterize scaffold degradation to determine the cell-
mediated degradation rate and mechanism. By identifying the cell-mediated degradation
mechanism, hydrogels can be optimized for future use as wound healing and tissue regener-
ation scaffolds. In order to determine the overall mechanism of cell-mediated degradation,
we first characterize degradation of hydrogels without hMSCs by hydrolytic and enzymatic
degradation. These degradation mechanisms are compared to cell-mediated degradation
to determine how both degradation mechanisms contribute to cell-mediated degradation.
In addition to characterizing cell-mediated degradation, our experiments show hMSCs are
viable within these hydrogels, even after experiencing stress. Our measurements determine
enzymatic degradation dominates the cell-mediated degradation mechanism, indicating
cell-secreted enzymes are primarily responsible for hMSC-laden hydrogel degradation.
3.1 Hydrolytic scaffold degradation
Hydrogels without hMSCs are first characterized during hydrolytic degradation. This work
is done without hMSCs to establish the kinetic constants for a homogenous hydrolytic
degradation reaction. Prior to characterization of scaffold degradation, the key parameters
13
3.1. HYDROLYTIC SCAFFOLD DEGRADATION
in bulk rheological measurements are determined. Briefly, the percent strain applied by
the rheometer is optimal at 1% strain to measure the linear viscoelastic region.
Figure 3.1: Hydrogel swelling, shown visually and quantified using bulk rheology. With
swelling, hydrogels visibly increase in size and color as growth medium diffuses into the
hydrogel. Note that the growth medium in our experiments is a reddish-pink color, and as
growth medium diffuses into the hydrogel, the hydrogel also becomes a bright pink color.
Hydrogel swelling is complete in approximately 4 hours and decreases the initial elastic
moduli, G′0, of the scaffold.
Another key parameter to determine is the time for complete hydrogel swelling. As
seen in Figure 3.1, when hydrogels swell during incubation in growth medium, there is a
significant change in appearance, as the hydrogel increases in size and decreases in stiffness
as growth medium diffuses into the scaffold. The effect of hydrogel swelling is quantified
using bulk rheology, which measures a decrease in the elastic moduli over the swelling
period, the first four hours of incubation in growth medium, until the moduli becomes
constant and the scaffold is fully swollen. Since measuring the elastic moduli is also the
primary method for tracking hydrogel degradation, it is important to use the swollen
modulus as the initial modulus, G′0. Therefore, a four hour time point, after swelling is
complete, is included in all experiments and used as the initial elastic modulus.
Bulk rheological measurements characterize hydrolytic hydrogel degradation, quantify-
ing the change in elastic moduli, G′. Hydrogels without cells degrade by hydrolysis of the
ester linkage on PEG molecules, which occurs during incubation in water-based growth
medium. As seen in Figure 3.2a, the elastic moduli is measured as a function of time
14
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Figure 3.2: Hydrolysis of PEG-norbornene hydrogel scaffolds without hMSCs. a) Bulk
rheological measurements of the elastic moduli, G′, as a function of time throughout degra-
dation. b) Normalized elastic moduli, G′/G′0 , as a function of time. This data is fit to
Equation 3.1, resulting in a hydrolysis kinetic constant, kh = 7.5× 10−3± 7.1× 10−4 hr−1.
over the course of the hydrogel degradation reaction. Complete degradation takes ap-
proximately two weeks. The decrease in the elastic moduli quantifies degradation of the
hydrogel. As the ester linkages on the PEG molecules hydrolyze, there is less scaffold con-
nectivity, which results in an overall decrease in scaffold stiffness and loss of the hydrogel
structure. In Figure 3.2b, the elastic moduli is normalized by the initial elastic moduli,
G′0, and modeled. Hydrolysis follows first-order reaction kinetics, and is modeled by
G′
G′0
= e−kht (3.1)
where kh is the hydrolysis kinetic constant and t is time. This results in a hydrolysis kinetic
constant of 7.5×10−3±7.1×10−4 hr−1. This value agrees with literature values, which range
15
3.2. NON-CELLULAR ENZYMATIC SCAFFOLD DEGRADATION
from 2.1× 10−2 hr−1 to 4.2× 10−4 for similar hydrogel chemistries [16,64–66]. Individual
hydrolysis replicate experiments, fits and kinetic constants are included for reference in
Figure 3.3.
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Figure 3.3: Normalized elastic moduli, G′/G′0, as a function of time for hydrolysis of
hydrogels without hMSCs. Hydrolysis follows first-order kinetics and the data for each
experiment is fit to Equation 3.1. These graphs show the individual experiments and the
resulting hydrolysis kinetic constant, kh.
3.2 Non-cellular enzymatic scaffold degradation
Prior to measuring cell-mediated scaffold degradation, enzymatic degradation of our hy-
drogel scaffold is characterized. Degradation is initiated by immersing the hydrogel in a
0.3 mg/mL collagenase solution. Collagenase is a mixture of enzymes that include MMPs,
making this is a method to characterize homogeneous enzymatic hydrogel degradation
prior to hMSC encapsulation. Figure 3.4a is bulk rheology of non-cellular enzymatic scaf-
fold degradation. The elastic moduli decreases with time, which occurs on a much faster
time scale when compared to hydrolytic degradation. Note that since the time of degra-
dation is a function of the collagenase concentration, changing the enzyme concentration
can be used to vary the time of degradation. While lowering the enzyme concentration
can lengthen the reaction, it is unlikely that it would lengthen the experiment to the two
week period of hydrolysis. We have also designed this experiment to happen on a fast time
scale so that hydrolysis does not significantly contribute to the degradation reaction, and
the experimental results characterize only enzymatic degradation.
Non-cellular enzymatic degradation is modeled by taking into account cleavage of the
MMP degradable cross-linker, deactivation of collagenase and using material balances and
16
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b
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Figure 3.4: Non-cellular enzymatic degradation, initiated by immersing hydrogels without
hMSCs in a 0.3 mg/mL collagenase solution. a) Bulk rheology measures the elastic moduli,
G′, as a function of time. b) Normalized elastic moduli, G′/G′0, as a function of time.
Enzymatic degradation is modeled using Equation 3.2, resulting in an enzymatic kinetic
constant, k∗ = 86.7± 0.71 M−1 s−1.
Michaelis-Menten kinetics. For the cleavage of the MMP degradable cross-linker, this con-
siders the probability, P , of a given cross-link being cleaved. The probability is quantified
in Equation 3.2, where
Ncross−link
Ncross−link0
is the normalized number of cross-links within the hy-
drogel, and G′/G′0 is the normalized elastic moduli, at a given time. In this model, the
normalized number of cross-links is equivalent to the normalized elastic moduli, G′/G′0.
The enzymatic kinetic constant, k∗ is then determined from this model,
P =
Ncross−link
Ncross−link0
=
G′
G′0
= e
k∗[collagenase]0
kd
(e−kdt−1)
(3.2)
where [collagenase]0 is the initial concentration of collagenase and kd is the first-order rate
constant [1, 15, 65]. The initial concentration of collagenase is equal to 2.31 × 10−6 M for
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our experiments. The deactivation of collagenase follows a first-order decay. Using the
previously measured half-life of collagenase, ≈ 48 hr, the first-order rate constant kd is 0.02
hr−1 [1,15,31]. Equation 3.2 is fit to the normalized elastic moduli data, Figure 3.4b, and
results in an enzymatic kinetic constant of 86.7 ± 0.71 M−1 s−1. Our enzymatic kinetic
constant falls within the literature range of 50 to 11,000 M−1 s−1 [14]. The wide range
of values in the literature is because previous work measured the cleavage of this specific
MMP degradable cross-linker sequence by single MMPs (MMP-1, MMP-2, MMP-3, MMP-
8 or MMP-9) [14]. Individual non-cellular enzymatic degradation replicate experiments,
fits and kinetic constants are included for reference in Figure 3.5.
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Figure 3.5: Normalized elastic moduli, G′/G′0, as a function of time for individual non-
cellular enzymatic degradation experiments degraded by a 0.3 mg/mL collagenase solution.
The data is fit to Equation 3.2, which is based on Michaelis-Menten kinetics. The collage-
nase first-order rate constant, kd, and initial concentration of collagenase, [collagenase0],
equal 0.02 hr−1 and 2.31 × 10−6 M, respectively, as discussed in the main text. Using
these constants and fitting the data to Equation 3.2, the enzymatic kinetic constant, k∗, is
determined for each experiment.
Bulk rheological measurements of non-cellular enzymatic degradation are compared
to previous microrheology measurements of non-cellular enzymatic degradation in this
material [1,2]. Previous multiple particle tracking microrheological characterization of this
scaffold determines a value of k∗ that falls within the range of enzymatic kinetic constants
in the literature, 2,100 M−1 s−1 [1,14]. In this work, a different collagenase concentration is
used to degrade the hydrogel, possibly accounting for the variability of the rate constant [1].
To account for the differences in these experiments, both bulk rheological and previous
microrheological measurements are normalized and plotted together in Figure 3.6. The
results are comparable over the entire degradation reaction regardless of measurement
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technique. Additionally, Equation 3.2 accurately describes both sets of data.
Figure 3.6: Normalized elastic moduli, G′/G′0, measured with bulk rheology and multi-
ple particle tracking microrheology, showing comparability between the characterization
techniques over the entire non-cellular enzymatic degradation reaction [1, 2].
Bulk rheological characterization of non-cellular enzymatic degradation is also com-
pared to hydrolytic degradation results. Time is normalized by the final time of degra-
dation, tf , as these experiments occur over different time scales. Hydrolysis takes ap-
proximately two weeks while non-cellular enzymatic degradation occurs over several hours.
Comparing the measurements and resulting fits, Figure 3.7, the shape of the curves are es-
sentially the same. This is a result of the moduli during both degradation reactions having
an exponential decay which is described in the models, Equations 3.1 and 3.2. However,
there are differences between the two sets of data, including a slower rate of change in the
moduli during hydrolysis, even after normalization. This indicates that the rate of loss of
cross-links by enzymatic degradation is more efficient than during hydrolytic degradation.
This will result in not only an overall faster degradation reaction, but more substantial loss
of structure in the initial stages of degradation when the scaffold is degraded enzymatically.
Characterizing hydrolytic and enzymatic degradation in hydrogel scaffolds without hM-
SCs results in accurate measurements of the kinetics of scaffold degradation and the reac-
tion constants. These experimental results and reaction constants are then compared to
measurements of cell-mediated degradation. This will determine the mechanism of scaffold
degradation, i.e. hydrolysis versus enzymatic degradation. From these initial experiments,
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Figure 3.7: Bulk rheology results for hydrogels without encapsulated hMSCs, comparing
hydrolysis and non-cellular enzymatic degradation.
we can use the measured reaction kinetics and constants to determine the contributions of
both hydrolytic and enzymatic degradation in cell-mediated hydrogel degradation.
3.3 Cell viability
Prior to bulk rheological characterization of cell-mediated degradation of hMSC-laden hy-
drogels, we must confirm that hMSCs remain viable during and after the measurement.
Hydrogels with hMSCs are swollen in growth medium, and hydrogels are stained with a
Live/Dead assay to determine temporal changes in cell viability. Live cells are stained
green due to intracellular esterase activity and dead cells are stained red due to lack of
membrane integrity [63]. By counting the number of live and dead cells, we quantify hMSC
viability for each hydrogel at various times throughout our experiments. Viability is first
measured after only incubating cell-laden hydrogels at 37◦C and 5% CO2 with no exter-
nal forces applied. These experiments will be referred to as “incubation viability”. The
resulting data, Figure 3.8, shows that incubation viability remains high with only a slight
decrease in viability over time. Additionally, cell imaging shows that cells are motile within
the hydrogel. Figure 3.8 also shows hMSC stretching increases over time. This motility is
indicative of hMSC viability within the hydrogel, as hMSCs are motile cells and naturally
migrate in their environment [25,28,35,36].
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Figure 3.8: Incubation viability for hydrogels with encapsulated hMSCs quantified using
a Live/Dead Assay. (Inset) Fluorescent images of live hMSCs at 4, 24, 48 and 120 hours
after hMSC encapsulation. Data and images show high viability and increased motility
with time. Scale bars are 250 µm.
Since hMSCs encapsulated in the hydrogels are exposed to ambient conditions during
bulk rheological characterization, additional viability testing is done to confirm hMSC via-
bility does not decrease during these experiments. During incubation, CO2 is absorbed into
the growth medium and is expected to have a relatively quick desorption from the hydrogels.
Our hydrogels are water-based, and previous work has determined that CO2 desorption in
water at physiological temperatures occurs in five to ten minutes [67]. Therefore, it can be
assumed that there will be CO2 desorption from hydrogels before the completion of a bulk
rheology experiment.
Due to this, we measure viability in hydrogels with encapsulated hMSCs that are ex-
posed to ambient conditions without growth medium for up to thirty minutes. These ex-
periments are done without growth medium to create the harshest environmental change a
hydrogel will experience. All bulk rheological measurements are taken in growth medium.
This is referred to as “exposure viability”. As seen in Figure 3.9, exposure viability re-
sults show no notable change in hMSC viability over a thirty minute time period. Since
each bulk rheology experiment only exposes the hMSC-laden hydrogels for about fifteen
minutes, it can be concluded that exposure to natural CO2 conditions should not impact
viability during bulk rheology experiments. These experiments show that any changes in
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Figure 3.9: Exposure viability of hydrogels with encapsulated hMSCs exposed to atmo-
spheric conditions without growth medium for 0 to 30 minutes. Fluorescent images of live
cells at (a) 0, (b) 10, (c) 20 and (d) 30 minutes. (e) Quantification of percent viability
over the same time period. There is no significant change in viability over 30 minutes,
indicating this exposure does not cause significant cell death.
hMSC viability is a result of the shear applied during bulk rheology experiments, rather
than exposure to ambient conditions.
After confirming both incubation and exposure viability remains high, cell viability is
determined after hMSC-laden hydrogels are sheared on the rheometer, which is referred
to as “sheared viability”. For these experiments, hMSC-laden hydrogels are incubated
immediately after gelation until they are measured on the rheometer, where they experience
shear, and then viability is completed immediately after the bulk rheology experiment.
Figure 3.10 is a quantification of cell viability, where time is the incubation time following
gelation and prior to bulk rheological characterization. In Figure 3.10, there is a slight
decrease in viable cells after hMSC-laden hydrogels are sheared, but the sheared viability
results are comparable and remain within error of incubation viability values. This indicates
that hMSCs encapsulated in these hydrogels can survive bulk rheological measurements,
and, therefore, hMSCs can withstand stresses when encapsulated within these hydrogels.
Individual sheared viability replicate experiments are shown in Figure 3.11 for reference.
Additionally, hMSC viability is monitored at several time points following bulk rheology
measurements. These experiments determine if additional hMSC death occurs at later time
points following the initial application of stress. In this experiment, hMSC-laden hydrogels
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Figure 3.10: hMSC viability as a function of time (shown as percent of viable cells),
comparing sheared viability, where hMSC-laden hydrogels are sheared on the rheometer,
to incubation viability, where hMSC-laden hydrogels do not experience shear.
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Figure 3.11: Individual experiments of sheared viability for hMSC-laden hydrogels. These
graphs show hMSC viability as a function of time after hMSC-laden hydrogels are sheared
on the rheometer.
have viability measured at 0, 24 or 48 hours after shearing on the rheometer. Note that
in real time, all shearing occurs at 48 hours and viability measurements are completed
at 48, 72 or 96 hours after hydrogel gelation, respectively. As seen in Figure 3.12, 91
± 10 % of hMSCs are viable immediately (zero hours) after shearing. hMSC viability
remains constant 24 and 48 hours after shearing, with values of 87 ± 9.0% and 85 ± 8.0%
respectively. This indicates that minimal to no additional hMSC death occurs hours after
hMSCs experience stress.
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Figure 3.12: hMSC viability as a function of time at 0, 24 and 48 hours of incubation
following shearing on the rheometer. Note that for each of these experiments, shearing is
completed 48 hours after hydrogel formation, so viability is completed on hydrogels at 48,
72 and 96 hours, respectively, in real time.
3.4 Cell-mediated degradation
After confirming hMSC viability, bulk rheology characterizes cell-mediated hydrogel degra-
dation. Figure 3.13a shows the decrease in modulus over time. In Figure 3.13a, the initial
elastic moduli of hMSC-laden hydrogels is 5−6× less than hydrogels without hMSCs. The
initial elastic moduli of hydrogels with hMSCs is likely lower due to encapsulated hMSCs
taking up additional space within the hydrogel and preventing cross-linking. hMSCs are
on the micrometer scale and cross-links are on the nanometer scale, so the encapsulation
of hMSCs prevents additional cross-links from forming. Therefore, the hydrogel will have
fewer cross-links, resulting in a decrease in stiffness characterized by a lower initial elastic
moduli. This can be verified by comparing the estimated number of cross-links lost in a
hydrogel to the elastic moduli data for hydrogels with and without hMSCs. In an ideal
system where 100 % of cross-links form, the maximum dimension of a pore in a hydrogel
without hMSCs is approximately 10 nm, while hMSC-laden hydrogels have an average
maximum pore length of about 17 nm. When factoring in that cross-linking efficiency is
30 % (determined from bulk rheological measurements), 80 % of cross-links are lost when
hMSCs are encapsulated in a hydrogel. This is compared to bulk rheology data, where
swollen hydrogels with hMSCs are about 100 Pa, whereas hydrogels without hMSCs are
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550 Pa, which also measures about 80 % of cross-links are lost.
b
a
Figure 3.13: Cell-mediated enzymatic degradation. a) Elastic moduli, G′, as a function of
time, characterized with bulk rheology throughout the degradation reaction. b) Normalized
elastic moduli, G′/G′0 as a function of time. This data is fit to Equation 3.3, where kd and
k∗ are the first-order rate and enzymatic kinetic constants, respectively. This fit resulted
in an initial MMP concentration, [MMP0], of 1.52 × 10−7 ± 2.05 × 10−8 M for a hMSC
encapsulation concentration of 2× 105 cells/mL.
The normalized elastic moduli, G′/G′0, is modeled to determine the degradation mech-
anism for hydrogels with encapsulated hMSCs. Data sets are fit to an enzymatic degrada-
tion model based on Michaelis-Menten kinetics that described the collagenase experiments.
These experimental results were initially fit with hydrolytic, enzymatic and a combination
of hydrolytic and enzymatic degradation kinetic models. The only model that fit the data
is an enzymatic degradation model, indicating that hMSC-mediated scaffold degradation
is due to MMP degradation within the scaffold and hydrolysis accounts for minimal scaf-
fold degradation. During these measurements, the hydrogel is degraded enzymatically by
cell-secreted MMPs, rather than by a collagenase solution. Due to this, modifications are
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made, and the resulting equation describes cell-mediated degradation
G′
G′0
= e
k∗[MMP ]0
kd
(e−kdt−1)
(3.3)
where the initial concentration of MMPs, [MMP ]0, is incorporated into the equation. Since
collagenase is a solution of enzymes that includes MMPs, the first-order rate constant, kd,
used in the previous enzymatic model, is used, and equals 0.02 hr−1. Additionally, the
previously determined enzymatic kinetic constant, k∗, is used to account for enzymatic
degradation, which equals 86.7 ± 0.71 M−1s−1.
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Figure 3.14: Normalized elastic moduli, G′/G′0, as a function of time for individual cell-
mediated degradation experiments. The data is fit to Equation 3.3, which is based on
Michaelis-Menten kinetics. The first-order rate constant, kd, and enzymatic kinetic con-
stant, k∗, are determined in previous non-cellular degradation experiments, and are 0.02
hr−1 and 86.7 M−1s−1, respectively. Using these constants and fitting to Equation 3.3,
the initial concentration of MMPs secreted by hMSCs, [MMP0], is determined for each
measurement of hydrogels with an encapsulated hMSC concentration of 2× 105 cells/mL.
Since the initial concentration of secreted MMPs is unknown, we use Equation 3.3 to
fit for [MMP0], which provides an approximation of the initial MMP concentration se-
creted by encapsulated hMSCs. This value is 1.52 × 10−7 ± 2.05 × 10−8 M in a hydrogel
with 2× 105 cell/mL. Literature has confirmed the presence of specific MMPs and studies
how MMPs can be used to regulate cell behavior, particularly involved with inflamma-
tion, tissue regeneration and cancer cell applications [57, 68–70]. However, no estimate
of a cell-secreted MMP concentration appears in these works, especially when encapsu-
lated in hydrogels [57, 68–70]. This model gives the first quantitative estimate of MMPs
secreted by hMSCs encapsulated within these hydrogels, which can be used to target a
specific degradation rate when designing these materials. Therefore, additional knowledge
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about hMSC-secreted MMPs helps to increase the tailorability of these hydrogels in specific
wound healing applications, by matching the rate of hydrogel degradation to the rate of
tissue regeneration within a specific wound. Individual cell-mediated degradation replicate
experiments, fits and corresponding initial MMP concentrations are included in Figure 3.14
for reference.
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Figure 3.15: Initial concentration of MMPs secreted by hMSCs as a function of hMSC
encapsulation concentration. When more hMSCs are encapsulated in these hydrogels,
more MMPs are secreted by the cells, resulting in a higher MMP concentration in the
hydrogel.
hMSC-laden hydrogels can also be tailored by altering the hMSC concentration within
the hydrogel. All previous experiments encapsulated hMSCs in hydrogels at a concentration
of 2× 105 cells/ mL. In order to determine how hMSC concentration affects cell-mediated
degradation in hMSC-laden hydrogels, bulk rheology experiments also characterize hy-
drogels with encapsulated hMSCs at concentrations of 0.5 × 105 and 1 × 105 cells/ mL.
Elastic moduli data at each concentration is fit to Equation 3.3, which fits for [MMP ]0,
the initial concentration of MMPs secreted by hMSCs. From this, [MMP ]0 is found to be
1.04×10−7±1.4×10−8 M and 1.15×10−7±1.3×10−8 M for hMSC concentrations of 0.5×105
and 1 × 105 cells/ mL, respectively. From this study, as seen in Figure 3.15, we find that
as the concentration of hMSCs encapsulated within the hydrogels increases, the concentra-
tion of MMPs secreted by the cells also increases. This is an expected result, when more
hMSCs are present, more MMPs are secreted that actively degrade the hydrogel to enable
cell motility, which changes the rate of hydrogel degradation. The change in [MMP0] is
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statistically significant between 1×105 and 2×105 cell/mL, but is within error for 0.5×105
and 1 × 105 cells/mL. The values being within error for the lower concentrations is not
unexpected. In this low cell concentration, we expect lower overall MMP secretion. Ad-
ditionally, with the smaller change between the two lower hMSC concentrations, a smaller
decrease in the change of [MMP0] is expected. This shows that altering the hMSC con-
centration provides another method to optimize cell-mediated hydrogel degradation rates
for different wound healing and tissue regeneration applications.
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Figure 3.16: Comparison of hydrolytic (gray line), non-cellular enzymatic (black, solid line)
and cell-mediated (dashed line) scaffold degradation.
In Figure 3.16, all degradation reactions are plotted together. Since all of the previ-
ously discussed types of degradation occur on different time scales, all elastic moduli data
are normalized, which enables direct comparison of all the degradation mechanisms. The
hydrolytic degradation rate is slower than the non-cellular enzymatic and cell-mediated
degradation rates. When comparing hydrolytic degradation to cell-mediated degradation
without normalizing time, degradation of hydrogels with encapsulated hMSCs occurs at
a rate approximately 4× faster than hydrolytic degradation. This indicates hydrolysis
plays a minimal role in the overall cell-mediated degradation mechanism. As cells secrete
MMPs, the MMP degradable cross-linker is cleaved, thus degrading the hydrogel at a faster
rate when compared to hydrolysis alone. On the other hand, when comparing cell-mediated
degradation to non-cellular enzymatic degradation, these fits are closely aligned, and nearly
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overlap. The initial collagenase and MMP concentration are an order of magnitude differ-
ent, [collagenase0] ≈ 2.3×10−6 and [MMP0] ≈ 1×10−7 M, which accounts for deviations
in degradation data. This indicates that cell-mediated degradation is dominated by an en-
zymatic degradation mechanism. This confirms that as cells are actively secreting MMPs,
these enzymes degrade the hydrogel on a time scale much faster than hydrolysis, thereby
minimizing effects from hydrolytic degradation. Therefore, cell-mediated degradation is
dominated by enzymatic degradation mechanism.
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Chapter 4
Conclusions
PEG-N hydrogel degradation is characterized to determine the mechanism of cell-mediated
degradation. Bulk rheology is used to determine the kinetics of three types of degradation:
hydrolytic, non-cellular enzymatic and cell-mediated degradation. Hydrolytic degradation
occurs due to hydrolysis of the ester linkage in the PEG molecules when hydrogels are
incubated in growth medium. These experiments result in a hydrolysis kinetic constant,
kh = 7.5 × 10−3 ± 7.1 × 10−4 hr−1. Non-cellular enzymatic degradation is initiated by
incubating hydrogels in a collagenase solution. This cleaves the MMP degradable cross-
linker in the hydrogel, and results in an enzymatic kinetic constant, k∗ = 86.7± 0.71 M−1
s−1.
Prior to measuring cell-mediated scaffold degradation, hMSC viability measurements
show that these hydrogels maintain high hMSC viability and provide an environment where
hMSCs survive in the presence of stress from bulk rheological characterization. Once high
hMSC viability is confirmed, bulk rheology characterizes cell-mediated hydrogel degrada-
tion. In these experiments, we determine that cell-mediated degradation is due to MMP-
secretion and hydrolytic degradation is minimal. To model this reaction, the enzymatic
degradation model developed for non-cellular enzymatic degradation is modified. Constants
from hydrolytic and non-cellular enzymatic degradation are used to determine the initial
concentration of MMPs in the scaffold. By changing the concentration of encapsulated
hMSCs, we measure that the amount of MMPs in the hydrogel increases with increasing
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hMSC concentration. This work provides important new information about cell-mediated
degradation. Namely, the mechanism of scaffold degradation has a minimal contribution
from hydrolysis and is due to enzymatic degradation by cell-secreted MMPs. This work
also provides a method to estimate the initial concentration of MMPs present in a cell-
laden hydrogel scaffold. These results characterize the evolving material properties of these
hydrogels throughout degradation, which can be used to optimize cell-laden hydrogels in
future regenerative medicine and wound healing applications.
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